Meta Biomed Co. Ltd (059210) — Cash Flow Reinvestment Rate
Meta Biomed Co. Ltd (059210) has a Cash Flow Reinvestment Rate of 18.28x as of September 2025, reinvesting ₩19.27 Billion (capex ₩4.44 Billion plus investments ₩14.83 Billion) from operating cash flow of ₩1.05 Billion. See Meta Biomed Co. Ltd (059210) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meta Biomed Co. Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Meta Biomed Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Meta Biomed Co. Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Meta Biomed Co. Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Meta Biomed Co. Ltd. See how financially flexible is Meta Biomed Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.41x | ₩54.47 Billion | ₩22.63 Billion | ₩11.10 Billion | ▲ +6.0% |
| 2023 | 2.27x | ₩23.20 Billion | ₩10.22 Billion | ₩11.49 Billion | ▼ -30.6% |
| 2022 | 3.27x | ₩29.98 Billion | ₩9.16 Billion | ₩15.41 Billion | ▲ +333.1% |
| 2021 | 0.76x | ₩8.42 Billion | ₩11.14 Billion | ₩2.07 Billion | ▼ -62.1% |
| 2020 | 1.99x | ₩9.69 Billion | ₩4.86 Billion | ₩2.23 Billion | ▼ -26.6% |
| 2019 | 2.72x | ₩7.78 Billion | ₩2.86 Billion | ₩7.56 Billion | ▲ +76.6% |
| 2016 | 1.54x | ₩7.74 Billion | ₩5.03 Billion | ₩6.13 Billion | ▼ -26.0% |
| 2015 | 2.08x | ₩10.25 Billion | ₩4.93 Billion | ₩7.79 Billion | ▲ +67.7% |
| 2013 | 1.24x | ₩4.60 Billion | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩5.26 Billion | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩8.22 Billion | ₩4.10 Billion | ₩8.22 Billion | — |